Carril-Ajuria, L., Colomba, E., Romero-Ferreiro, C., Cerbone, L., Ratta, R., Barthelemy, P., Vindry, C., Fléchon, A., Cherifi, F., Boughalem, E., Linassier, C., Fornarini, G., Rebuzzi, S. E., Gross-Goupil, M., Saldana, C., Martin-Soberón, M., de Velasco, G., Manneh, R., Pernaut, C., Sanchez de Torre, A., Flippot, R., Escudier, B., & Albiges, L. (2023). frontline immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients with poor performance status. European journal of cancer, 180, 21–29. http://access.bl.uk/ark:/81055/vdc_100174251270.0x000025